News|Videos|June 27, 2024
Conversations With Patients About Mild/Moderate Multiple Sclerosis
Author(s)Stephen Krieger, MD
Heidi Crayton, MD
Heidi Crayton, MD
The expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.
Advertisement
- What is important for physicians to share with different types of patients and with patients at different junctures of their MS journey?
- Are there any patients with mild disease who won’t be treated with DMTs?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Daridorexant Provides Relief for Insomnia in Women During Menopausal Transition
2
International Committee Publishes 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis
3
RELIEV-CM Pilot Study Data Further Supports ShiraTronics’ Neuromodulation Device to Treat Chronic Migraine
4
New Study Finds Link Between Gut Hormone GLP-1 and NMOSD Symptoms, Paving Way for Targeted Treatments
5